After only a few days from the article pubblished on the local newspaper il Mattino, another important Italian newspaper has written about Hepavac. Last 8 February la Repubblica in the Oncoline column, totally dedicated to tumour therapies, diagnosis and prevention, has illustrated the important potentalities of our project if the coming clinical trail phase was a success! http://www.repubblica.it/oncologia/2017/02/08/news/tumore_al_fegato_immunoterapia_vaccino_terapeutico_studio_hepavac-157863666/
The Italian newspapaer Il Mattino, in its health supplement entitled Salute e Benessere, has dedicated an article to HEPAVAC also available on the online newspaper http://www.ilmattino.it/. Maria Pirro, the journalist who interviewed Dr.Buonaguro a few days ago, describes accurately the objectives of the project exalting the great expextations and hopes of this highly innovative vaccine.
Another opportunity, after the publication, last July, in Il sole 24 ore supplement Platinum, to make Hepavac known countrywide.